Ophthalmology News and Research

RSS
Ophthalmology is the specialized field of medicine that focuses on the health of the eye. It includes the anatomy, physiology and diseases that may affect the eye. Historically, the science of ophthalmology encompassed all aspects of visual function, both in health and in illness. Additionally, ophthalmology also includes animal eyes as ocular function and optic diseases are similar among humans and animals.
NSU College of Optometry investigators awarded NIH grant to study convergence insufficiency

NSU College of Optometry investigators awarded NIH grant to study convergence insufficiency

Researchers create three-dimensional complement of human retinal tissue in a dish

Researchers create three-dimensional complement of human retinal tissue in a dish

UAB ophthalmologists offer tips to prevent firework related injuries

UAB ophthalmologists offer tips to prevent firework related injuries

Study: The brain controls cellular process that leads to glaucoma

Study: The brain controls cellular process that leads to glaucoma

Ocugen's OCU100 gets FDA orphan drug designation for treatment of retinitis pigmentosa

Ocugen's OCU100 gets FDA orphan drug designation for treatment of retinitis pigmentosa

RPB grants $500,000 to accelerate treatments for Retinitis Pigmentosa

RPB grants $500,000 to accelerate treatments for Retinitis Pigmentosa

EHR solutions provider, ChartLogic, partners with Kareo

EHR solutions provider, ChartLogic, partners with Kareo

Regular grape consumption may play role in eye health

Regular grape consumption may play role in eye health

Study shows high BP drugs may raise likelihood of age-related macular degeneration

Study shows high BP drugs may raise likelihood of age-related macular degeneration

Viewpoints: It's past time to move on VA's problems; administration should report new health law numbers

Viewpoints: It's past time to move on VA's problems; administration should report new health law numbers

IRIDEX’ Micropulse technology safe, durable for treating glaucoma

IRIDEX’ Micropulse technology safe, durable for treating glaucoma

AbbVie receives HUMIRA orphan drug designation from FDA for treatment of non-infectious uveitis

AbbVie receives HUMIRA orphan drug designation from FDA for treatment of non-infectious uveitis

Leica Microsystems and Med X Change announce select Leica surgical microscopes are now available with integrated 1080p recording

Leica Microsystems and Med X Change announce select Leica surgical microscopes are now available with integrated 1080p recording

Shire intends to submit NDA for lifitegrast to treat dry eye disease

Shire intends to submit NDA for lifitegrast to treat dry eye disease

NovaBay completes enrollment of patients in global Phase 2b viral conjunctivitis trial

NovaBay completes enrollment of patients in global Phase 2b viral conjunctivitis trial

Eleven Biotherapeutics reports financial results and operational highlights for Q1 2014

Eleven Biotherapeutics reports financial results and operational highlights for Q1 2014

Amakem commences Phase 2 dose-ranging study of AMA0076 drug for treatment of glaucoma

Amakem commences Phase 2 dose-ranging study of AMA0076 drug for treatment of glaucoma

People who consume diet rich in resveratrol are likely to develop cardiovascular disease

People who consume diet rich in resveratrol are likely to develop cardiovascular disease

Scientists develop non-invasive technique to determine gene carriers  for retinitis pigmentosa

Scientists develop non-invasive technique to determine gene carriers for retinitis pigmentosa

Researchers discover new class of drugs to treat nystagmus eye condition

Researchers discover new class of drugs to treat nystagmus eye condition

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.